Search Results - "Mincheff, M."
-
1
-
2
PB2175: TRYPAN BLUE AND FLOW CYTOMETRY CELL VIABILITY TESTING OF PACKED OR DILUTED CRYOPRESERVED AT ‐80ºC HEMATOPOIETIC STEM CELLS SHOW SIMILAR RESULTS
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
3
Changes in Donor Leukocytes during Blood Storage. Implications on Post- Transfusion Immunomodulation and Transfusion-Associated GVHD
Published in Vox sanguinis (01-06-1998)“…Freshly drawn peripheral blood granulocytes, monocytes and NK cells express Fas‐L following activation. Fully functional soluble Fas‐L (sFas‐L) is released and…”
Get full text
Journal Article Conference Proceeding -
4
Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?
Published in Journal of B.U. ON. (01-09-2009)“…Increasing evidence has demonstrated that the immune system is able to mount responses against tumors and that these responses can be enhanced using a number…”
Get more information
Journal Article -
5
Immune responses against PSMA after gene-based vaccination for immunotherapy - A: results from immunizations in animals
Published in Cancer gene therapy (01-04-2006)“…Two plasmid DNA vaccines, encoding either products that are retained in the cytosol and degraded in the proteasome (tVacs; hPSMAt), or secreted proteins…”
Get full text
Journal Article -
6
-
7
Biochemical Nature and Mapping of PSMA Epitopes Recognized by Human Antibodies Induced after Immunization with Gene-based Vaccines
Published in Anticancer research (01-11-2005)“…Background: A possible new target for immunotherapy is the prostate-specific membrane antigen (PSMA). The aim of the present study was to define potential PSMA…”
Get full text
Journal Article -
8
In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer—changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-γ lymphokine profile
Published in Critical reviews in oncology/hematology (01-07-2001)“…In order to provoke an immune response, a tumor vaccine should not only maximize antigen-specific signals, but should also provide the necessary…”
Get full text
Journal Article -
9
Blood transfusion and immunomodulation: a possible mechanism
Published in Vox sanguinis (01-01-1993)“…To induce an immunogenic response in vivo, an antigen-presenting (stimulator) cell must present both antigen-specific (class II MHC) and an accessory signal to…”
Get more information
Journal Article -
10
Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model
Published in Transplantation (27-10-1995)“…During refrigerated storage leukocytes in donor blood progressively undergo apoptosis followed by secondary necrosis. Using an inbred rodent transfusion model,…”
Get more information
Journal Article -
11
Blood transfusion, blood storage and immunomodulation
Published in Immunological investigations (01-01-1995)“…Allogeneic blood transfusion is the most frequent allotransplantation procedure performed on a routine basis with no prior HLA-typing. Roughly 50% of the…”
Get more information
Journal Article -
12
-
13
Fas and Fas Ligand Expression on Human Peripheral Blood Leukocytes
Published in Vox sanguinis (1998)“…Objectives: Study of Fas and Fas ligand (Fas-L) expression, as well as sFas-L release, by fresh human peripheral blood leukocytes. Methods: Flow cytometry,…”
Get full text
Journal Article -
14
Costimulatory signals necessary for induction of T cell proliferation
Published in Transplantation (01-04-1990)“…Two separate signals are required for induction of T cell proliferation. In an attempt to identify them we used polyclonal T cell activation with Con A, which…”
Get more information
Journal Article -
15
PF779 VIABILITY OF HEMATOPOETIC STEM CELLS FOLLOWING STORAGE AT −80OC WITH 5% DIMETHYLSULFOXIDE AND HEMATOLOGIC RECOVERY IN TRANSPLANTED MYELOMA PATIENTS
Published in HemaSphere (01-06-2019)“…Background: Dimethylsulfoxide (DMSO) is a major intracellular cryoprotectant, used for cryopreservation of stem cells. It is toxic to both cells and patients…”
Get full text
Journal Article -
16
PB2365 CELL DOSE AND HEMATOLOGIC RECOVERY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
Published in HemaSphere (01-06-2019)“…Background: The relation between the dose of the infused hematopoietic stem cells and the time of hematologic recovery after autologous transplantation has…”
Get full text
Journal Article -
17
Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial
Published in European urology (01-08-2000)“…Animal studies have indicated that the use of syngeneic dendritic cells that have been transfected ex vivo with DNA for tumor-specific antigen results in tumor…”
Get more information
Journal Article -
18
Tularemia outbreak, Bulgaria, 1997-2005
Published in Emerging infectious diseases (01-04-2006)“…The 1997-2005 tularemia outbreak in Bulgaria affected 285 people. Ten strains were isolated from humans, a tick, a hare, and water. Amplified fragment length…”
Get full text
Journal Article -
19
Induction of primary mixed leukocyte reactions with ultraviolet B or chemically modified stimulator cells
Published in Transplantation (01-12-1989)“…Treatment of stimulator cells with 0.1% paraformaldehyde for 60 sec or ultraviolet-B (UV-B) irradiation (1000 J/m2) eliminates their ability to elicit T cell…”
Get more information
Journal Article -
20